LYCA · ISSUER CIK 1806540
Lycia Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Lycia Therapeutics, Inc. insiders reported $37.7M of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Venrock Healthcare Capital Partners III, L.P. (10% Owner), with $37.7M.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$37.7MInsider buying
$0.00Insider selling
+$37.7MNet open-market
Oct 28, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 202617:28 | Oct 26, 2026 | LYCA | 10% Owner · +5 joint | C · Convert | — | +7,025,307 | 1,393,882 | — | — | ||
| Oct 27, 202618:38 | Oct 27, 2026from Oct 23, 2026 | LYCA | 10% Owner · +8 joint | P · Buy | $18.41 | +2,045,440 | 6,825,233 | +43% | +$37.7M | — | +50.6% |
| Oct 27, 202618:38 | Oct 26, 2026 | LYCA | 10% Owner · +8 joint | C · Convert | — | +4,779,793 | 4,832,732 | +9029% | — |